Have a personal or library account? Click to login
Antioxidant Properties of Resveratrol and its Protective Effects in Neurodegenerative Diseases Cover

Antioxidant Properties of Resveratrol and its Protective Effects in Neurodegenerative Diseases

Medical Journal of Cell Biology
Volume 4 (2014): Issue 2 (December 2014)
By: Joanna Gerszon,  Aleksandra Rodacka and  Mieczysław Puchała  
Open Access
|Dec 2014

References

  1. [1] Albani D, Polito L, Batelli S, De Mauro S, Fracasso C, Martelli G et al. The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta(1-42)peptide. J. Neurochem. 2009; 110: 1445-1456.10.1111/j.1471-4159.2009.06228.x
    Search in Google Scholar
  2. [2] Amri A, Chaumeil JC, Sfa r S, Charrueau C. Administration of resveratrol: What formulation solutions to bioavailability limitations? J Control Release. 2012; 10; 158(2): 182-193.10.1016/j.jconrel.2011.09.083
    Search in Google Scholar
  3. [3] Ashu J And Flint Beal M. Mitochondrial Dysfunction in Neurodegenerative Diseases. J Pharmacol Exp Ther. 2012; 342(3): 619-630.10.1124/jpet.112.192138
    Search in Google Scholar
  4. [4] Balcerczyk A, Pirola L. Therapeutic potential of activators and inhibitors of sirtuins. BioFactors. 2010; 36(5): 383-393.10.1002/biof.112
    Search in Google Scholar
  5. [5] Candelario-Jalil E, Slawik H, Ridelis I, Waschbischa, Akundi RS, Hull M, Fiebich BL. Regional distribution of the prostaglandin E2 receptor EP1 in the rat brain: accumulation in Purkinje cells of the cerebellum. Journal of Molecular Neuroscience. 2005; 27(3): 303-310.10.1385/JMN:27:3:303
    Search in Google Scholar
  6. [6] Canto C, Auwerx J. Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab. 2009; 7: 325-331.10.1016/j.tem.2009.03.008
    Search in Google Scholar
  7. [7] Camont L, Cottart CH, Rhayem Y, Nivet-Antoine V, Djelidi R, Collin F, Beaudeux JL, Bonnefont- Rousselot D. Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions. Anal Chim Acta. 2009; 634(1): 121-128.10.1016/j.aca.2008.12.003
    Search in Google Scholar
  8. [8] Carrizzo A, Forte M, Damato A, Trimarco V, Salzano F, Bartolo M, Maciag A, Puca AA, Vecchione C. Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases. Food Chem Toxicol. 2013; 61: 215-226.10.1016/j.fct.2013.07.021
    Search in Google Scholar
  9. [9] Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French paradox revisited. Front Pharmacol. 2012; 3: 141.10.3389/fphar.2012.00141
    Search in Google Scholar
  10. [10] Cao H, Pan X, Li C, Zhou C, Deng F, Li T. Density functional theory calculations for resveratrol. Bioorg Med Chem Lett. 2003; 13(11): 1869-1871.10.1016/S0960-894X(03)00283-X
    Search in Google Scholar
  11. [11] Caruso F, Tanski J, Villegas-Estrada A, Rossi M. Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure. J Agric Food Chem. 2004; 52(24): 7279-7285.10.1021/jf048794e15563207
    Search in Google Scholar
  12. [12] Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-{kappa}B signaling. J. Biol. Chem. 2005; 280: 40364-40374.
    Search in Google Scholar
  13. [13] Chen CY, Jang JH, Li MH, Surh YJ. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun. 2005; 331(4): 993-1000.10.1016/j.bbrc.2005.03.23715882976
    Search in Google Scholar
  14. [14] Clark J, Silvaggi JM, Kiselak T, Zheng K, Clore EL, Dai Y, Bass CE, Simon DK. Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf. PLoS One. 2012; 7(11): e48925.10.1371/journal.pone.0048925349213323145024
    Search in Google Scholar
  15. [15] Cordova-Gomez M, Galano A, Raul J, Alvarez-Idaboy JR. Piceatannol, a better peroxyl radical scavenger than resveratrol. RSC Advances. 2013; 3: 20209-20218.10.1039/c3ra42923g
    Search in Google Scholar
  16. [16] Donmez G, Wang D, Cohen DE, Guarente L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell. 2010; 142: 320-332.10.1016/j.cell.2010.06.020291163520655472
    Search in Google Scholar
  17. [17] Donmez G, Quteiro TF. SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol. Med. 2013; 5: 344-352.
    Search in Google Scholar
  18. [18] Delmas D, Aires V, Limagne E, Dutatarte P, Mazue F, Ghiringhelli F, Latruffe N. Transport, stability, and biological activity of resveratrol. Ann N Y Acad Sci. 2011; 1215: 48-59.10.1111/j.1749-6632.2010.05871.x21261641
    Search in Google Scholar
  19. [19] Delmas D, Jannin B, Latruffe N. Resveratrol: natural properties against atherosclerosis, associated pro-inflammatory effects and aging. Molecular Nutrition & Food Research. 2005, 49(5): 377-39510.1002/mnfr.20040009815830334
    Search in Google Scholar
  20. [20] Dudka J, Gieroba R, Korga A, Burda n F, Matysiak W, Jodlowska-Jedrych B, Mandziuk S, Korobowicz E, Murias M. Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity. Evidence-Based Complementary and Alternative Medicine. 2012; Article ID 60618: 10.10.1155/2012/606183352248823258992
    Search in Google Scholar
  21. [21] Feng Y, Wang XP, Yang SG, Wang YJ, Zhang X, Dua XT, Suna XX, Zhao M, Huang L, Liu RT . Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. NeuroToxicology. 2009; 30(6): 986-995.10.1016/j.neuro.2009.08.01319744518
    Search in Google Scholar
  22. [22] Franco SS, De Falco L, Ghaffa ri S, Brugnara C, Sinclair DA, Matte A, Iolascon A, Mohandas N, Bertoldi M, An X, Siciliano A, Rimmele P, Cappellini MD, Michan S, Zoratti E, Janin A, De Franceschi L. Resveratrol accelerates erythroid maturation by activation of FOXO3 and ameliorates anemia in beta-thalassemic mice. Haematologica. 2014; 99(2): 267-275.10.3324/haematol.2013.090076391295623975182
    Search in Google Scholar
  23. [23] Fukui M, Yamabe N, Kang KS, Zhu BT. Growth-stimulatory effect of resveratrol in human cancer cells. Mol Carcinog. 2010; 49(8): 750-759.10.1002/mc.2065020572158
    Search in Google Scholar
  24. [24] Gao J, Wang WY, Mao YW, Graff J, Guan JS, Pan L. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 2010; 466: 1105-1109.10.1038/nature09271292887520622856
    Search in Google Scholar
  25. [25] Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, Newgard CB, Farese RV Jr, Alt FW, Kahn CR, Verdin E. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 2010; 464(7285): 121-125.10.1038/nature08778284147720203611
    Search in Google Scholar
  26. [26] Holthoff JH, Woodling KA, Doerge DR, Burns ST, Hinson JA, Mayeux PR. Resver at r ol , a dietary polyphenolic phytoalexin, is a functional scavenger of peroxynitrite. Biochem Pharmacol. 2010; 80(8): 1260-1265.10.1016/j.bcp.2010.06.027293487320599800
    Search in Google Scholar
  27. [27] Hurst WJ, Glinski JA, Miller KB, Apgar J, Davey MH, Stuart DA. Survey of the trans-resveratrol and trans-piceid content of cocoa-containing and chocolate products. J Agric Food Chem. 2008; 24: 56(18): 8374-8378.10.1021/jf801297w18759443
    Search in Google Scholar
  28. [28] Hussein Mohammed A. A Convenient Mechanism for the Free Radical Scavenging Activity of Resveratrol, International Journal of Phytomedicine. 2011; 3: 459-469.
    Search in Google Scholar
  29. [29] Iuga C, Alvarez-Idaboy JR, Russo N. Antioxidant activity of trans-resveratrol toward hydroxyl and hydroperoxyl radicals: a quantum chemical and computational kinetics study. J Org Chem. 2012; 77(8): 3868-3877.10.1021/jo300213422475027
    Search in Google Scholar
  30. [30] Iwahara T, Bonasio R, Narendra V, Reinberg D. SIRT3 functions in the nucleus in the control of stress-related gene expression. Mol.Cell.Biol. 2012; 32: 5022-5034.
    Search in Google Scholar
  31. [31] Jensen JS, Wertz CF, O‘neill VA. Preformulation stability of trans-resveratrol and trans-resveratrol glucoside (Piceid). J Agric Food Chem. 2010; 58(3): 1685-1690.10.1021/jf903009f20055412
    Search in Google Scholar
  32. [32] Juan ME, Gonzalez-Pons E, Munuera T, Ballester J, Rodriguez-Gil JE, Planas JM. Trans-Resveratrol, a natural antioxidant from grapes, increases sperm output in healthy rats. J Nutr. 2005; 135(4): 757-760.10.1093/jn/135.4.75715795430
    Search in Google Scholar
  33. [33] Julien C, Tremblay C, Emond V, Lebbadi M, Salem N Jr., Bennett DA. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2009; 68: 48-58.
    Search in Google Scholar
  34. [34] Karuppag ounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s disease. Neurochem Int. 2009; 54(2): 111-118.10.1016/j.neuint.2008.10.008289290719041676
    Search in Google Scholar
  35. [35] Kavas GO, Ayral PA, Elhan AH. The Effects of Resveratrol on Oxidant/Antioxidant Systems and Their Cofactors in Rats. Adv Clin Exp Med. 2013; 22(2): 151-155.
    Search in Google Scholar
  36. [36] Kincaidand B, Bossy-Wetzel. Forever young: SIRT3 a shield against mitochondrial melt down, aging, and neurodegeneration. Frontiers in aging neurodegenearation. Front Aging Neurosci. 2013; 5: 48.
    Search in Google Scholar
  37. [37] Kopeć A, Piątkowska E, Leszczyńska T, Bieżanowska-Kopeć R. Health-promoting affects of resveratrol [in Polish]. ŻYWNOŚĆ. Nauka. Technologia. Jakość. 2011; 5(78): 5-15
    Search in Google Scholar
  38. [38] Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat. Rev. Neurol. 2013; 9: 25-34.
    Search in Google Scholar
  39. [39] Ladiwala AR, Lin JC, Bale SS, Marcelino-Cruz AM, Bhattacharya M, Dordcik JS, Tessier PM. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers. J Biol Chem. 2010; 285(31): 24228-24237.10.1074/jbc.M110.133108291134920511235
    Search in Google Scholar
  40. [40] Li Y, Cao Z, Zhu H. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol. Res. 2006; 53: 6-15.
    Search in Google Scholar
  41. [41] Li F, Gong Q, Dong H, Shi J. Resveratrol, A Neuroprotective Supplement for Alzheimer’s Disease. Curr Pharm Des. 2012; 18(1): 27-33.10.2174/13816121279891907522211686
    Search in Google Scholar
  42. [42] Lin TK, Chen SD, Chuang YC, Lin HY, Huang CR, Chuang JH, Wang PW, Huang SH, Tiao MM, Chen JB, Liou CW. Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy. Int J Mol Sci. 2014; 15(1): 1625-1646.10.3390/ijms15011625390789024451142
    Search in Google Scholar
  43. [43] Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur.J.Neurol. 2009; 16: 297-309.
    Search in Google Scholar
  44. [44] Mahal Hs, Mukherjee. Scavenging of reactive oxygen radicals by resveratrol: antioxidant effect. Research on Chemical Intermediates. 2006; 32(1): 59-71.10.1163/156856706775012941
    Search in Google Scholar
  45. [45] Marabaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer’s disease amyloid-beta peptides. J Biol Chem. 2005; 280(45): 37377-37382.10.1074/jbc.M50824620016162502
    Search in Google Scholar
  46. [46] Martin OJ, Lai L, Soundarapa ndian MM, Leone TC, Zorzano A, Keller MP, Attie AD Muoio DM, Kelly DP. A Role for Peroxisome Proliferator-Activated Receptor γ Coactivator-1 in the Control of Mitochondrial Dynamics During Postnatal Cardiac Growth. Circ Res. 2014; 114(4): 626-636.10.1161/CIRCRESAHA.114.302562406176824366168
    Search in Google Scholar
  47. [47] Mccall CE, Elgazzar M, Liu T, Vachharajani V, Yoza B. Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprograming during acute systemic inflammation. J. Leukoc.Biol. 2011; 90: 439-446.
    Search in Google Scholar
  48. [48] Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat.Rev.Immunol. 2009; 9: 692-703.
    Search in Google Scholar
  49. [49] Michan S, Sinclair. Sirtuins in mammals: insights into their biological function. Biochem J. 2007; 404(1): 1-13.10.1042/BJ20070140275345317447894
    Search in Google Scholar
  50. [50] Mikstacka R, Ignatowicz E. Chemopreventive and therapeutic affects of trans-resveratrol and its analogues in neoplastic diseases [in Polish]. Pol Merk Lek 2010; 168: 496-500.
    Search in Google Scholar
  51. [51] Miller NJ, Rice-Evans CA. Antioxidant activity of resveratrol in red wine. Clinical Chemistry. 1995; 41: 1789.10.1093/clinchem/41.12.1789
    Search in Google Scholar
  52. [52] Min SW, Cho SH, Zhou Y, Schroeder S, Haroutunian V, Seeley WW et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron. 2010; 67: 953-966.10.1016/j.neuron.2010.08.044303510320869593
    Search in Google Scholar
  53. [53] Min SW, Sohn PD, Cho SH, Swanson RA, Gan L. Sirtuins in neurodegenerative diseases: an update on potential mechanisms. Front Aging Neurosci. 2013; 5: 53.10.3389/fnagi.2013.00053378264524093018
    Search in Google Scholar
  54. [54] Mokni M, Elkahoui S, Limam F, Amri M, Aouani E. Effect of Resveratrol on Antioxidant Enzyme Activities in the Brain of Healthy Rat. Neurochemical Research. 2007; 32; 6: 981-987.10.1007/s11064-006-9255-z17401679
    Search in Google Scholar
  55. [55] Nakagawa T, Lomb DJ, Haigis MC, Guarente L. SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell. 2009; 137(3): 560-570.10.1016/j.cell.2009.02.026269866619410549
    Search in Google Scholar
  56. [56] Ng F, Tang BL. Sirtuins’ modulation of autophagy. J Cell Physiol. 2013; 228(12): 2262-70.10.1002/jcp.2439923696314
    Search in Google Scholar
  57. [57] Olas B. Resveratrol as a benefactor in prophylaxis of diseases in circulatory system [in Polish]. Kosmos problemy nauk biologicznych, Polskie Towarzystwo Przyrodników im. Kopernika. 2006; 55, 2-3: 271-272.
    Search in Google Scholar
  58. [58] Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofa lo RS, Griffith D, Griffor M, Loulakis P, Pabst B, Qiu X, Stockman B, Thanabal V, Varghese A, Ward J, Withka J, Ahn K. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 2010; 285(11): 8340-8351 10.1074/jbc.M109.088682283298420061378
    Search in Google Scholar
  59. [59] Park SJ, Ahmad F, Philp A, Baar K, Williams T, Lou H, Ke H, Rehmann H, Taussig R, Brown, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012; 148: 487-501.10.1016/j.cell.2012.01.017343180122304913
    Search in Google Scholar
  60. [60] Pope D, Madura JD, Cascio. M. β-Amyloid and Neprilysin Computational Studies Identify Critical Residues Implicated in Binding Specificity. J. Chem. Inf. Model. 2014.10.1021/ci500015m24650257
    Search in Google Scholar
  61. [61] Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010; 12: 662-667.10.1016/j.cmet.2010.11.01521109198
    Search in Google Scholar
  62. [62] Quincozes-Santos A, Gottfried C. Resveratrol modulates astroglial functions: neuroprotective hypothesis. Ann N Y Acad Sci. 2011; 1215: 72-78.10.1111/j.1749-6632.2010.05857.x21261643
    Search in Google Scholar
  63. [63] Richard T, Pawlus AD, Iglesias ML, Pedrot E,Waffo-Teguo P,Merillon JM, Monti JP. Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci. 2011; 1215: 103-108.10.1111/j.1749-6632.2010.05865.x21261647
    Search in Google Scholar
  64. [64] Riederer BM, Leuba G, Vernay A, Riederer IM. The role of the ubiquitin proteasome system in Alzheimer’s disease. Exp Biol Med (Maywood). 2011; 236(3): 268-76.10.1258/ebm.2010.01032721383047
    Search in Google Scholar
  65. [65] Robb EL, Page MM, Wiens BE, Stuart JA. Molecular mechanisms of oxidative stress resistance induced by resveratrol: Specific and progressive induction of MnSOD. Biochem. Biophys. Res. Commun. 2008; 367: 406-412.
    Search in Google Scholar
  66. [66] Rocha KK, Souza GA, Ebaid GX, Seiva FR, Cantaneo AC, Novelli EL. Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food Chem Toxicol. 2009; 47(6): 1362-1367.10.1016/j.fct.2009.03.01019298841
    Search in Google Scholar
  67. [67] Rodacka A, Strumillo J, Serafin E, Puchala M. Effect of Resveratrol and Tiron on The Inactivation of Glyceraldehyde-3-Phosphate Dehydrogenase Induced by Superoxide Anion Radical. Curr Med Chem. 2014; 21(8):1061-1069.10.2174/0929867311320666027424059224
    Search in Google Scholar
  68. [68] Rovilllain E, Mansfield L, Caetano C, Alvarez-Fernandez M, Caballero OL, Medema Rh et al. Activation of nuclear factor-kappaB signalling promotes cellular senescence. Oncogene 2011; 30: 2356-2366.10.1038/onc.2010.611308081121242976
    Search in Google Scholar
  69. [69] Ryan MJ, Jackson JR, Hao Y, Williamson CL, Dabkowski ER, Hollander JM, Alway SE. Suppression of oxidative stress by resveratrol after isometric contractions in gastrocnemius muscles of aged mice. J Gerontol A Biol Sci Med Sci. 2010; 65(8): 815-831.10.1093/gerona/glq080290378620507922
    Search in Google Scholar
  70. [70] Saunders LR, Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene. 2007; 26: 5489-5504.10.1038/sj.onc.121061617694089
    Search in Google Scholar
  71. [71] Scapag nini G, Vasto S, Abraham NG, Caruso C, Zella D, Fabio G. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol. 2011; 44(2): 192-201.10.1007/s12035-011-8181-5555493821499987
    Search in Google Scholar
  72. [72] Seo AY, Joseph AM, Dutta D, Hwang JCY, Aris JP, Leeuwenburgh C. New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J. Cell Sci. 2010; 123: 2533-2542.10.1242/jcs.070490291246120940129
    Search in Google Scholar
  73. [73] Son Y, Lee JH, Chung HT, Pae HO. Therapeutic Roles of Heme Oxygenase-1 in Metabolic Diseases: Curcumin and Resveratrol Analogues as Possible Inducers of Heme Oxygenase-1. Oxid Med Cell Longev. 2013; 639541.10.1155/2013/639541378651624101950
    Search in Google Scholar
  74. [74] Spa nier G, Xu H, Xia N, Tobias S, Deng S, Wojnowski L, Forstermann U, Li H. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol. 2009; 60(4): 111-116.
    Search in Google Scholar
  75. [75] Strumiłło J, Rodacka A, Puchała M. Relationship between structural lack of order and function in inherently unordered proteins [in Polish]. Postępy Biologii Komórki. 2013; 40(4): 602-627.
    Search in Google Scholar
  76. [76] Sueishi Y, Hori M. Nitric oxide scavenging rates of solubilized resveratrol and flavonoids. Nitric Oxide. 2013; 29: 25-29.10.1016/j.niox.2012.12.00223246439
    Search in Google Scholar
  77. [77] Szewczuk LM, Forti L, Stivalala, Penning TM. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem. 2004; 279(21): 22727-22737.10.1074/jbc.M31430220015020596
    Search in Google Scholar
  78. [78] Tadolini B, Juliano C, Piu L, Franconi F, Cabrini L. Resveratrol inhibition of lipid peroxidation. Free Radic Res. 2000; 33(1): 105-114 10.1080/1071576000030066110826926
    Search in Google Scholar
  79. [79] Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol.Cell. 2010; 40: 893-904.
    Search in Google Scholar
  80. [80] Tennen RI, Michishita-Kioi E, Chua KF. Finding a Target for Resveratrol. Cell. 2012; 148, 3: 387-389.
    Search in Google Scholar
  81. [81] Trela BC, Waterhouse AL. Resver at r ol : Isomeric molar absorbivities and stability. J. Agric. Food Chem. 1996; 44: 1253-1257.10.1021/jf9504576
    Search in Google Scholar
  82. [82] Vakhrusheva O, Smolka C, Gajawada P, Kostin S, Boettger T, Kubin T, Braun T, Bober E. Sirt 7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res. 2008; 102(6): 703-710.10.1161/CIRCRESAHA.107.16455818239138
    Search in Google Scholar
  83. [83] Van Ham TJ, Thijssen KL, Breitling R, Hofstra RM, Plasterek RH, Nollen EA. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoSGenet. 2008; 4(3): e1000027.10.1371/journal.pgen.1000027226541218369446
    Search in Google Scholar
  84. [84] Vang O, Ahmad N, Baile CA, Baur JA, Brown K, Csiszar A, Das DK, Delmas D, Gottfried C, Lin HY, Ma QY, Mukhopad hyay P, Nalini N, Pezzuto JM, Richard T, Shukla Y, Surh YJ, Szekeres T, Szkudelski T, Walle T, Wu JM. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PloS One. 2011; 6(6): 19881.10.1371/journal.pone.0019881311682121698226
    Search in Google Scholar
  85. [85] Vian MA, Tomao V, Gallet S, Coulomb PO, Lacombe JM. Simple and rapid method for cis- and trans- resveratrol and piceid isomers determination in wine by high-performance liquid chromatography using chromolith columns. J Chromatogr A. 2005; 2, 1085(2): 224-229.
    Search in Google Scholar
  86. [86] Westerheide SD, Anckar J, Stevens SM Jr, Sistonen L, Morimoto RI. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science. 2009; 323: 1063-1066.10.1126/science.1165946342934919229036
    Search in Google Scholar
  87. [87] Wu PF, Xie N, Zhang JJ, Guan XL, Zjou J, Long LH, Li YL, Xiong QJ, Zeng JH, Wang F, Chen JG. Resveratrol preconditioning increases methionine sulfoxide reductases A expression and enhances resistance of human neuroblastoma cells to neurotoxins. J Nutr Biochem. 2013; 24(6): 1070-1077.10.1016/j.jnutbio.2012.08.00523022493
    Search in Google Scholar
  88. [88] Yang J, Wang N, Li J, Zhang J, Feng P. Effects of resveratrol on NO secretion stimulated by insulin and its dependence on SIRT1 in high glucose cultured endothelial cells. Endocrine. 2010; 37(2): 365-372.10.1007/s12020-010-9314-820960276
    Search in Google Scholar
  89. [89] Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA et al. Modulation of NF-kBdependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004; 23: 2369-2380.10.1038/sj.emboj.760024442328615152190
    Search in Google Scholar
  90. [90] Yu LY , Wu ML, Li H, Chen XY, Wang Q, Sun Y, Kong QY, Liu J. Inhibition of STAT3 Expression and Signaling in Resveratrol-Differentiated Medulloblastoma Cells. Neoplasia. 2008; 10(7): 736-744.10.1593/neo.08304243500918592012
    Search in Google Scholar
  91. [91] Zhong L, D’urso A, Toiber D, Sebastian C, Henry RE, Vaddysirisack DD, Guimaraes A, Marinelli B, Wiksstrom JD, Nir T, Clish CB, Vaitheesvaran B, Iliopoulos O, Kurland I, Dor Y, Weissleder R, Shirihai OS, Ellisen LW , Espinosa JM, Mostoslavsky R. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell. 2010; 140(2): 280-293 10.1016/j.cell.2009.12.041282104520141841
    Search in Google Scholar
DOI: https://doi.org/10.2478/acb-2014-0006 | Journal eISSN: 2544-3577
Journal RSS Feed
Language: English
Page range: 97 - 117
Published on: Dec 30, 2014
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
resveratrol,
neuroprotection,
neurodegenerative diseases,
sirtuins,
protein aggregates
Related subjects:
Life sciences,
Molecular biology,
Biochemistry

© 2014 Joanna Gerszon, Aleksandra Rodacka, Mieczysław Puchała, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 4 (2014): Issue 2 (December 2014)